The cBioPortal for Cancer Genomics
癌症基因组学的 cBioPortal
基本信息
- 批准号:10528935
- 负责人:
- 金额:$ 145.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-05 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAmerican Association of Cancer ResearchArchitectureAreaBig DataBiological AssayBiological MarkersBiotechnologyCancer CenterCancer PatientClinicalCloud ComputingCodeCollaborationsCommunitiesCommunity OutreachComputer softwareConsultationsDana-Farber Cancer InstituteDataData AnalysesData SetDevelopmentEcosystemEducation and OutreachEnsureFundingFutureGenomicsGrowthImaging TechniquesInstitutionInternetLicensingMalignant NeoplasmsMemorial Sloan-Kettering Cancer CenterMolecularMolecular ProfilingPatient CarePediatric HospitalsPerformancePharmaceutical PreparationsPharmacologic SubstancePhiladelphiaPublishingResearchResearch PersonnelResourcesSamplingScientistSeriesServicesSiteTechnologyTractionTraininganticancer researchbasecBioPortalcancer carecancer genomicscancer initiationcommunity planningcomplex datadata miningdata pipelinedata sharingdata visualizationgenetic variantgenomic datagenomic profileshackathonhuman genome sequencingimprovedinsightinteroperabilitylarge datasetsmedical schoolsmolecular imagingnovelonline resourceopen sourceoutreachpersonalized medicineprecision medicineprecision oncologyprogramsresearch and developmentsocial mediasoftware developmenttooltreatment effecttumorusabilityuser-friendlyweb portalwebinar
项目摘要
PROJECT SUMMARY
Genomic sequencing of tumor samples is now a routine component of cancer care, providing unprecedented
insight into cancer initiation, progression, and treatment effects. Additionally, novel molecular profiling and
imaging techniques are gaining traction, generating ever more data. Ensuring that these data sets are easily
accessible and interpretable to scientists and clinicians is of vital importance. Towards this end, we seek to
evolve and expand the capabilities of the cBioPortal for Cancer Genomics, a unique platform that enables
interactive exploratory analysis of large-scale cancer genomic data. The cBioPortal is the most widely used
and most highly cited tool within the cancer genomics community. The public site, with data from 325 cancer
studies, is accessed by >34,000 unique users each month. The cBioPortal instance that supports AACR
Project GENIE, a multi-institutional data sharing initiative, now hosts genomic profiles from >120,000 tumors.
Since the software is available under an open source license, >65 cancer centers and pharmaceutical
companies have institutional installations of cBioPortal to analyze their own data. Multiple institutions are
making contributions to the software, including the five that are part of this application (Memorial Sloan
Kettering Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Princess Margaret Cancer
Centre, and Children’s Hospital of Philadelphia). To ensure that this vital resource continues to aid the cancer
research community and to keep pace with the rapidly advancing fields of cancer genomics and precision
cancer medicine, including the continuing increase in the number of profiled tumor samples, we propose to
actively sustain and evolve the cBioPortal platform. Specifically, we plan to make improvements across the
entire cBioPortal software architecture (Aim 1); this includes significant changes to address key performance
bottlenecks, a new API capable of supporting federated queries, a new App Store, and improvements to our
cloud infrastructure and data pipelines. We will also support several new molecular data types, add two entirely
new cBioPortal views, develop new features for precision oncology, and improve general usability (Aim 2). We
propose to continue funding a group of core developers across five institutions, expand the base of code
contributors, and continue to collaborate with The Hyve to support biotech and pharmaceutical companies (Aim
3). Finally, to maximize use in the scientific community, we plan to continue to improve community outreach,
user support, and training (Aim 4). These improvements will be necessary to ensure that cBioPortal continues
to provide an essential service for cancer research and development of new biomarkers and drugs, especially
as more cancer centers are using the cBioPortal as part of their precision medicine programs, and as
pharmaceutical companies are using it for internal research. We expect that, over the next few years, the
cBioPortal will continue to have a strong impact on all areas of cancer research and patient care.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ethan Cerami其他文献
Ethan Cerami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ethan Cerami', 18)}}的其他基金
Human Tumor Atlas Network: Data Coordinating Center Extension
人类肿瘤图谱网络:数据协调中心扩展
- 批准号:
10818705 - 财政年份:2023
- 资助金额:
$ 145.62万 - 项目类别:
Human Tumor Atlas Network: Data Coordinating Center Supplement
人类肿瘤图谱网络:数据协调中心补充
- 批准号:
10206514 - 财政年份:2018
- 资助金额:
$ 145.62万 - 项目类别:
Cancer Immunologic Data Commons (CIDC) Supplement Request
癌症免疫学数据共享 (CIDC) 补充请求
- 批准号:
10617928 - 财政年份:2017
- 资助金额:
$ 145.62万 - 项目类别: